Clinical trial
Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy
NCT00410696 · Armando Santoro, MD, Other · Completed
Key facts
| NCT number | NCT00410696 |
|---|---|
| Title | Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy |
| Official title | Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy With Peripheral Autologous Stem Cell Reinfusion in Patients With Hematological Neoplasms and Solid Tumors: Phase II Randomised Trial |
| Lead sponsor | Armando Santoro, MD, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hematological Neoplasms, Tumors |
| Intervention type | Drug |
| Interventions | Filgrastim, Pegfilgrastim |
| Enrollment | 80 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Dec 13, 2006 |
| Last update posted | Jul 1, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: